Chronic Cough
55
10
11
27
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
12 trials with published results (22%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.5%
3 terminated out of 55 trials
90.0%
+3.5% vs benchmark
20%
11 trials in Phase 3/4
44%
12 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (55)
Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation
Remodelling of the Lower Airways in Chronic Cough
Chronic Cough and Small Fiber Neuropathy
Finnish Children´s Protracted Cough
Feasibility, Acceptability, and Safety Trial of Brief, Breath Control-Focused Acceptance and Commitment Therapy in Adults With Chronic Cough
Efficacy of Behavioral Therapy for Chronic Refractory Cough
Comprehensive Analysis of the Swallowing Mechanism Using High-resolution Manometry With Impedance
Study to Investigate the Efficacy and Safety of SC0023, in Adults With Refractory or Unexplained Chronic Cough
A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough
A Prospective, Randomized, Double-blind Study on the Effects of Different Anesthesia Strategies on Postoperative Cough in Patients Undergoing Video-assisted Thoracoscopic Surgery.
Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases
A Study of Efficacy and Safety of AX-8 in Chronic Cough
An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
Validation Study With a Non-CE Marked Medical Device (MD)
Prospective Study on the Evaluation, Patient Reported Outcomes and Effectiveness of Treatment for Chronic Cough
Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients
The Real-world Treatment Satisfaction by Gefapixiant in RCC
Chronic COUGH Management in Interstitial Lung DisEase